Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Novartis Pharmaceutical
Boehringer Ingelheim
Ministry of Science and Technology, Taiwan (MOST 111-2314-B-075-071)
- License Information
-
More Information
Article History
Accepted: 3 April 2023
First Online: 26 September 2023
Declarations
:
: Chun-Jui Huang, Chieh-Hua Lu, and Kuang-Chung Shih declare that they have no conflict of interest.
: The datasets used and/or analyzed during the current study are available from the corresponding author on request.
: The trial protocol was approved by the Institutional Review Board of the Tri-Service General Hospital (Approval Number: 098-01-015) on Dec 14, 2009.
: All participants signed a written informed consent form prior to enrollment.
: Not applicable.
: Not applicable.
: Conceptualization, Kuang-Chung Shih; Data Curation, Chun-Jui Huang; Formal Analysis, Chun-Jui Huang, Chieh-Hua Lu, and Kuang-Chung Shih; Writing—Original Draft Preparation, Chun-Jui Huang, Writing—Review & Editing, Chun-Jui Huang, Chieh-Hua Lu, and Kuang-Chung Shih; all authors provided critical feedback and helped shape the research, analysis and manuscript, as well as provided final approval of the manuscript.
